Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals

ClinicalTrials.gov ID: NCT00393276

Public ClinicalTrials.gov record NCT00393276. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 6, 2026, 7:57 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Optimizing Vaccine Responsiveness in HIV-1 and HCV Infections by Identifying Determinants of Responsiveness: A Pilot Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Infection with either HIV or hepatitis C virus (HCV) affects immune system responses. The purpose of this study is to investigate the immune responses to two different vaccine formulations in HIV-infected, HCV-infected, and HCV/HIV- coinfected individuals.

Study identification

NCT ID
NCT00393276
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Enrollment
29 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2007
Primary completion
Jun 30, 2009
Completion
Jun 30, 2009
Last update posted
Oct 31, 2021

2007 – 2009

United States locations

U.S. sites
11
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
UCSD Antiviral Research Center CRS San Diego California 92103
Ucsf Aids Crs San Francisco California 94110
University of Colorado Hospital CRS Aurora Colorado 80045
IHV Baltimore Treatment CRS Baltimore Maryland 21201
Massachusetts General Hospital Clinical Research Site (MGH CRS) CRS Boston Massachusetts 02114
Columbia P&S CRS New York New York 10032-3732
Duke Univ. Med. Ctr. Adult CRS Durham North Carolina 27710
Case CRS Cleveland Ohio 44106-5083
MetroHealth CRS Cleveland Ohio 44109
The Ohio State University Medical Center Columbus Ohio 43210
Trinity Health and Wellness Center CRS Dallas Texas

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00393276, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2021 · Synced Sep 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00393276 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →